Life Science Unicorns From A China Investment Perspective

This book systematically expounds the history of the global pharmaceutical industry in the past 50 years, adopts the philosophical theory of "paradigm" and "paradigm shift", analyzes the current investment hot areas, and predicts potential “life sciences unicorns”. Written by many industry opinion leaders, this book is a rare professional work that combines practice with theory, combines Chinese characteristics with a global perspective, and combines business with science. With the purpose of popularizing knowledge and education, this book uses a large number of cases, introductions, recommended books and report catalogs, so that readers can learn and think systematically and comprehensively.

Managing directors and partners from ten of the nation's leading VC firms on spotting the best investments in life sciences.

Industrialization supported by industrial hubs has been widely associated with structural transformation and catch-up. But while the direct economic benefits of industrial hubs are significant, their value lies first and foremost in their contribution as incubators of industrialization, production and technological capability, and innovation. The Oxford Handbook of Industrial Hubs and Economic Development adopts an interdisciplinary approach to examine the conceptual underpinnings, review empirical evidence of regions and economies, and extract pertinent lessons for policy reasearchers and practitioners on the key drivers of success and failure for industrial hubs. This Handbook illustrates the diverse and complex nature of industrial hubs and shows how they promote industrialization, economic structural transformation, and technological catch-up. It explores the implications of emerging issues and trends such as environmental protection and sustainability, technological advancement, shifts in the global economy, and urbanization.

This book examines the medical biotechnology industry in India through the lens of a critical political economy. It discusses the sharp trajectory of growth in the biotechnology business and the state of investments, subsidies, and patents which propelled the rise of the industry in India. The book uses in-depth interviews and case studies to analyse the roles of various financial actors, state institutions, and academia in the medical biotechnology ecosystem. Focusing on the relationship between India’s neoliberal policies and the swift growth of the industry, the author examines the merits and demerits of the current market-driven biomedical ecosystem exploring the trends in the industry, biomedical start-ups, the use of human resources, and capital accumulation process. The book reiterates and emphasises the need for the democratisation of scientific and medical work and for striking a balance between economic gains and public health priorities. Comprehensive and insightful, this book will be of interest to scholars and researchers of science technology society studies, public health, economics, business studies, medical sociology, public policy, and political science.

With a blend of storytelling and analysis Sebastian Mallaby makes sense of the seeming randomness of success in venture capital. We learn about some of the most iconic triumphs and infamous disasters in the history of tech

Holistic nutritionist and highly-regarded blogger Sarah Britton presents a refreshing, straight-forward approach to balancing mind, body, and spirit through a diet made up of whole foods. Sarah Britton's approach to plant-based cuisine is about satisfaction--foods that satiate on a physical, emotional, and spiritual level. Based on her knowledge of nutrition and her love of cooking, Sarah Britton crafts recipes made from organic vegetables, fruits, whole grains, beans, lentils, nuts, and seeds. She explains how a diet based on whole foods allows the body to regulate itself, eliminating the need to count calories. My New Roots draws on the enormous appeal of Sarah Britton's blog, which strikes the perfect balance between healthy and delicious food. She is a "whole food lover," a cook who makes simple accessible plant-based meals that are a pleasure to eat and a joy to make. This book takes its cues from the rhythms of the earth, showcasing 100 seasonal recipes. Sarah simmers thinly sliced celery root until it mimics pasta for Butternut Squash Lasagna, and whips up easy raw chocolate to make homemade chocolate-nut butter candy cups. Her recipes are not about sacrifice, deprivation, or labels--they are about enjoying delicious food that's also good for you.

Financing Entrepreneurship and Innovation in China provides an overview of the current state-of-affairs in the financing of private innovations in China. While country-level innovation can take many forms, the focus is on the funding of business start-ups and entrepreneurial ventures. The monograph has four specific objectives: (1) to present an economic framework for evaluating the central challenges associated with the financing of entrepreneurial ventures in China, (2) to evaluate the relative size and importance of the channels through which private initiatives for innovation in China are currently being funded, (3) to survey the academic evidence on potential financing constraints currently facing private initiatives in innovation, and (4) to discuss public policy implications that may arise from these findings, as well as to outline the type of future research that may best inform Chinese policy makers. After the introduction, Section 2 begins with a review of the central economic themes in entrepreneurial finance. Section 3 reviews the channels through which external funding now reach entrepreneurs in China. Section 4 further explores the problems engendered by China's IPO regulations. Section 5 summarizes the findings, discusses policy implications, and explores potential venues for future research. The authors conclude that China's current IPO regulations represent a serious impediment to two important near-term goals espoused by the Chinese government - to bring more high-technology firms back to mainland stock markets, and to be included at a meaningful weight in international stock indices, particularly the MSCI Emerging Market Index.

Entrepreneur's guide for starting and growing a business to a public listing